Azmi Nabulsi
2022
In 2022, Azmi Nabulsi earned a total compensation of $2.8M as Chief Operating Officer at Phathom Pharmaceuticals, a 36% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $274,838 |
---|---|
Option Awards | $1,947,240 |
Salary | $525,000 |
Other | $15,375 |
Total | $2,762,453 |
Nabulsi received $1.9M in option awards, accounting for 70% of the total pay in 2022.
Nabulsi also received $274.8K in non-equity incentive plan, $525K in salary and $15.4K in other compensation.
Rankings
In 2022, Azmi Nabulsi's compensation ranked 1,326th out of 5,756 executives tracked by ExecPay. In other words, Nabulsi earned more than 77.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,326 | 77th |
Manufacturing | 654 | 79th |
Chemicals And Allied Products | 242 | 83rd |
Drugs | 221 | 83rd |
Pharmaceutical Preparations | 159 | 84th |
Nabulsi's colleagues
We found two more compensation records of executives who worked with Azmi Nabulsi at Phathom Pharmaceuticals in 2022.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020